Pathway to Cures
Overview
P2C's venture philanthropy fund invests only in companies that offer the potential to change the lives of those living with inheritable blood and bleeding disorders.
Related on NestLens
Last updated July 15, 2026
P2C's venture philanthropy fund invests only in companies that offer the potential to change the lives of those living with inheritable blood and bleeding disorders.
Last updated July 15, 2026